Employer – The University of Texas M. D. Anderson Cancer Center Location – Houston, TX Job Number – 7047713 Application Deadline – Open Until Filled Job Description SUMMARY: Seeking a postdoctoral fellow to join a laboratory focusing on molecular mechanisms of prostate cancer, with ...
Read More »
MD Anderson scientists do next-generation analysis of complete tumor genomes from exosomes Pancreatic cancer tumors spill their molecular secrets into the blood stream, shedding their complete DNA and RNA wrapped inside protective lipid particles that make them ripe for analysis ...
Read More »
from Houston Public Media by Carrie Feibel MD Anderson launched “Moon Shots” in 2012 with the aim of speeding up the movement of basic discoveries from the laboratory to the actual cancer patient. This year, six new cancers have been ...
Read More »
Codiak Is Launched To Exploit The Exosome | Chemical … cen.acs.org/…/Codiak–Launched-Exploit-… Chemical & Engineering News 6 days ago – Looking to exploit a natural cellular communication highway, a new company, Codiak BioSciences, has launched with $80 million in venture … Codiak ...
Read More »
Codiak BioSciences Inc. announced today the closing of the first portion of a planned $80+ million Series A and B financing. The company also executed license and sponsored research agreements with The University of Texas MD Anderson Cancer Center in ...
Read More »
from Medical News Today by Catharine Paddock PhD A study that successfully differentiated patients with pancreatic cancer from those with another pancreatic disease using a new biomarker, could lead to a blood test that detects pancreatic cancer early enough for ...
Read More »
Exosome RNA Exosome RNA Research & Industry News
